[go: up one dir, main page]

WO2007143959A3 - Tablet containing metformin - Google Patents

Tablet containing metformin Download PDF

Info

Publication number
WO2007143959A3
WO2007143959A3 PCT/CZ2007/000056 CZ2007000056W WO2007143959A3 WO 2007143959 A3 WO2007143959 A3 WO 2007143959A3 CZ 2007000056 W CZ2007000056 W CZ 2007000056W WO 2007143959 A3 WO2007143959 A3 WO 2007143959A3
Authority
WO
WIPO (PCT)
Prior art keywords
tablet containing
containing metformin
percent
weight
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CZ2007/000056
Other languages
French (fr)
Other versions
WO2007143959A2 (en
Inventor
Juraj Zeleznik
Beata Vladovicova
Viera Kormanova
Viera Hubinova
Mikulas Lehocky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zentiva KS
Original Assignee
Zentiva KS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva KS filed Critical Zentiva KS
Publication of WO2007143959A2 publication Critical patent/WO2007143959A2/en
Publication of WO2007143959A3 publication Critical patent/WO2007143959A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Tablet containing metformin or pharmacologically acceptable salts thereof, where the active substance release is controlled by a hydrophobic polymer; the tablet contains 60 to 80 percent by weight of the active substance and 9 to 25 percent by weight of the hydrophobic polymer.
PCT/CZ2007/000056 2006-06-16 2007-06-18 Tablet containing metformin Ceased WO2007143959A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZPV2006-392 2006-06-16
CZ20060392A CZ300698B6 (en) 2006-06-16 2006-06-16 Metformin-containing tablet

Publications (2)

Publication Number Publication Date
WO2007143959A2 WO2007143959A2 (en) 2007-12-21
WO2007143959A3 true WO2007143959A3 (en) 2008-02-14

Family

ID=38721769

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CZ2007/000056 Ceased WO2007143959A2 (en) 2006-06-16 2007-06-18 Tablet containing metformin

Country Status (2)

Country Link
CZ (1) CZ300698B6 (en)
WO (1) WO2007143959A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8323692B2 (en) 2002-02-21 2012-12-04 Valeant International Bermuda Controlled release dosage forms
US8022075B2 (en) 2005-11-30 2011-09-20 Fujifilm Ri Pharma Co., Ltd. Diagnostic and remedy for disease caused by amyloid aggregation and/or deposition
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033448A1 (en) * 1997-12-23 1999-07-08 Merck Patent Gmbh Tablet for instant and prolonged release of one or more active substances
WO2003004009A1 (en) * 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition
WO2003072089A1 (en) * 2002-02-21 2003-09-04 Biovail Laboratories Inc. Controlled release dosage forms
WO2004012699A2 (en) * 2002-08-05 2004-02-12 Torrent Pharmaceuticals Limited Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent
WO2005037255A1 (en) * 2003-10-16 2005-04-28 Novartis Ag Tablet with aqueous based-sustained release coating

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2320900C (en) * 1998-03-19 2009-10-27 Bristol-Myers Squibb Company Biphasic controlled release delivery system for high solubility pharmaceuticals and method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999033448A1 (en) * 1997-12-23 1999-07-08 Merck Patent Gmbh Tablet for instant and prolonged release of one or more active substances
WO2003004009A1 (en) * 2001-07-02 2003-01-16 Geneva Pharmaceuticals, Inc. Pharmaceutical composition
WO2003072089A1 (en) * 2002-02-21 2003-09-04 Biovail Laboratories Inc. Controlled release dosage forms
WO2004012699A2 (en) * 2002-08-05 2004-02-12 Torrent Pharmaceuticals Limited Modified release composition comprising coated micro matrix particles containing the high soluble active ingredient and a release controlling agent
WO2005037255A1 (en) * 2003-10-16 2005-04-28 Novartis Ag Tablet with aqueous based-sustained release coating

Also Published As

Publication number Publication date
CZ2006392A3 (en) 2007-12-27
WO2007143959A2 (en) 2007-12-21
CZ300698B6 (en) 2009-07-22

Similar Documents

Publication Publication Date Title
WO2009058798A3 (en) Orally disintegrated dosage form
CA2661102C (en) Thiophene derivatives as s1p1/edg1 receptor agonists
WO2009057079A3 (en) Novel pyrimidine derivatives
WO2009113703A3 (en) Orally-disintegrating solid preparation
WO2007084728A3 (en) 2-imino-benzimidazoles
MX2010005889A (en) Novel thiophene derivatives.
PL1906939T3 (en) Use of a partially neutralized, anionic (meth)acrylate copolymer as a coating for the production of a medicament releasing active substance at reduced ph values
WO2007003962A3 (en) Gpcr agonists
WO2007003961A3 (en) Gpcr agonists
WO2008132710A3 (en) Pharmaceutical nimodipine compositions
TW200744588A (en) Pharmaceutical composition for external use
WO2008090555A3 (en) Medical devices having a matrix adhered thereof
WO2011012816A3 (en) Pharmaceutical formulation
WO2009059701A3 (en) Sustained release tablets with hydromorphone
WO2009060952A1 (en) Novel preparation
WO2008123395A1 (en) Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
EP2241310A3 (en) Modified release formulations of emoxypine
WO2008093838A1 (en) Pyridyl imidazolidine derivative having sulfamoyl group, and pharmaceutical use thereof
WO2009072334A1 (en) Core particle for pharmaceutical preparation
WO2009038412A3 (en) Beta-secretase inhibiting compounds
WO2009144551A3 (en) Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium level in the blood
SI1994926T1 (en) Valsartan formulations
WO2009069355A1 (en) Method for screening of therapeutic agent for allergic airway inflammation and/or airway hypersensitivity using il-17rb-positive nkt cell
WO2007143959A3 (en) Tablet containing metformin
WO2011058336A3 (en) Tablet comprising gum arabic

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07721845

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07721845

Country of ref document: EP

Kind code of ref document: A2